Peter D. Kies
2009
In 2009, Peter D. Kies earned a total compensation of $588.2K as Chief Financial Officer at Inovio Pharmaceuticals, a 109% increase compared to previous year.
Compensation breakdown
| Bonus | $255,056 |
|---|---|
| Option Awards | $109,446 |
| Salary | $223,700 |
| Total | $588,202 |
Kies received $255.1K in bonus, accounting for 43% of the total pay in 2009.
Kies also received $109.4K in option awards and $223.7K in salary.
Rankings
In 2009, Peter D. Kies' compensation ranked 6,303rd out of 9,885 executives tracked by ExecPay. In other words, Kies earned more than 36.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,303 out of 9,885 | 36th |
Division Manufacturing | 2,298 out of 3,690 | 38th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 350 out of 607 | 42nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 186 out of 331 | 44th |
Industry Surgical and Medical Instruments and Apparatus | 122 out of 217 | 44th |
Source: SEC filing on April 12, 2010.
Kies' colleagues
We found four more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2009.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019